Patent | Date |
---|
Bifunctional Enzyme with Y-Glutamylcysteine Synthetase and Glutathione Synthetase Activity and Uses Thereof App 20080194701 - Griffith; Owen W. ;   et al. | 2008-08-14 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses Grant 7,022,737 - Stamler , et al. April 4, 2 | 2006-04-04 |
Anti-microbial agents derived from methionine sulfoximine analogues App 20040157802 - Horwitz, Marcus ;   et al. | 2004-08-12 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses App 20030207815 - Stamler, Jonathan S. ;   et al. | 2003-11-06 |
Treating asthma by preventing and/or accomodating for S-nitrosothiol breakdown App 20030170316 - Gaston, Benjamin ;   et al. | 2003-09-11 |
Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown Grant 6,617,355 - Gaston , et al. September 9, 2 | 2003-09-09 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses Grant 6,608,110 - Stamler , et al. August 19, 2 | 2003-08-19 |
Manipulating Nitrosative Stress To Kill Pathologic Microbes, Pathologic Helminths And Pathologically Proliferating Cells Or To Upregulate Nitrosative Stress Defenses App 20030096870 - Stamler, Jonathan S. ;   et al. | 2003-05-22 |
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase Grant 6,231,894 - Stamler , et al. May 15, 2 | 2001-05-15 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically, proliferating cells or to upregulate nitrosative stress defenses Grant 6,180,824 - Stamler , et al. January 30, 2 | 2001-01-30 |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses Grant 6,057,367 - Stamler , et al. May 2, 2 | 2000-05-02 |
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction Grant 5,723,448 - Gross , et al. March 3, 1 | 1998-03-03 |
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction Grant 5,545,625 - Gross , et al. August 13, 1 | 1996-08-13 |
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body Grant 5,436,271 - Griffith July 25, 1 | 1995-07-25 |
Heme binding compounds and use thereof Grant 5,424,447 - Griffith , et al. June 13, 1 | 1995-06-13 |
Use of arginase to control nitric oxide formation Grant 5,419,901 - Griffith * May 30, 1 | 1995-05-30 |
Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an .alpha..sub.1 adrenergic agonist Grant 5,395,612 - Griffith , et al. March 7, 1 | 1995-03-07 |
Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension Grant 5,312,835 - Kilbourn , et al. * May 17, 1 | 1994-05-17 |
L-buthionine-S-sulfoximine and methods of making Grant 5,294,736 - Griffith March 15, 1 | 1994-03-15 |
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor Grant 5,286,739 - Kilbourn , et al. February 15, 1 | 1994-02-15 |
Substituted arginines and substituted homoarginines and use thereof Grant 5,281,627 - Griffith January 25, 1 | 1994-01-25 |
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body Grant 5,273,875 - Griffith December 28, 1 | 1993-12-28 |
Use of arginase to control nitric oxide formation Grant 5,196,195 - Griffith March 23, 1 | 1993-03-23 |
N.sup.6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body Grant 5,132,453 - Griffith July 21, 1 | 1992-07-21 |
Isolating aminoarginine and use to block nitric oxide formation in body Grant 5,059,712 - Griffith October 22, 1 | 1991-10-22 |
Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor Grant 5,028,627 - Kilbourn , et al. July 2, 1 | 1991-07-02 |